Medical and financial implications of discontinuing a statewide free insulin program involving 3,720 people.
In 1981 a statewide program supplying free insulin to 3,720 patients of state health clinics was discontinued. We attempted to assess whether this action had an adverse effect medically and financially on those concerned. A computer randomized sample of 351 patients (9%) was studied by personal interview and questionnaire. Information obtained focused on certain events that occurred 18 months before and after the program ceased. Measurements used to determine medical impact were number of hospitalizations, emergency room and physician visits, changes in weight and glucose levels, and episodes of ketoacidosis. Financial impact was measured by cost of hospitalization and physician visits. Our results revealed no significant changes in any of the medical parameters studied except for fasting serum glucose levels above 300 mg/dl, which occurred less frequently after the free insulin program was discontinued. There were fewer hospitalizations, more visits to physicians, and no change in number of emergency room visits after discontinuance of the free program. The overall cost saving was estimated to be +883,558 for the 18-month study period, in addition to the +550,000 the plan had been costing the state.
Nicholas
W C
WC
Diabetes Control Program, Mississippi State Department of Health, Jackson.
Watson
R L
RL
D001786:Blood Glucose / Q000032:analysis; D003365:Costs and Cost Analysis; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy / Q000191:economics*; D005260:Female; D006076:Government; D006760:Hospitalization; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D008483:Medical Assistance / Q000191:economics; D008875:Middle Aged; D008922:Mississippi; D010820:Physicians / Q000706:statistics & numerical data; D012189:Retrospective Studies; D013219:State Government
D001786:Blood Glucose; D007328:Insulin